KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases
Go to source), which is now the most common type of coronavirus in the US, has been leading to a rise in infections, according to the CDC: Centers for Disease Control and Prevention.
What is KP.3.1.1 COVID Variant
KP.3.1.1, of the Omicron family, is among many currently co-circulating JN.1-derived variants in the US, Xinhua news agency reported. Like other variants, it contains mutations in its genetic material that may affect its transmissibility, severity, or resistance to immunity from vaccines or prior infections. Researchers are actively studying KP.3.1.1 to understand its characteristics and impacts on public health.
COVID in Children
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.
‘The KP.3.1.1 #Covid19 variant is on the rise in the U.S. With mutations affecting its spread and resistance, stay informed and protect yourself! #HealthUpdate’
For the two-week period ending August 17, KP.3.1.1 is predicted to account for between 31 percent and 43 percent of Covid-19 clinical specimens, compared to between 20 percent and 26 percent for the two-week period ending August 3, according to the latest CDC data released. The rise in prevalence of KP.3.1.1 comes as markers of Covid-19 activity, including test positivity, emergency department visits, and hospitalizations, remain elevated, particularly among adults ages 65 years and older and children younger than 2 years. CDC recommends that the public get coronavirus vaccines to protect against serious illness from Covid-19 infection. Updated Covid-19 vaccines that can provide protection during the 2024 to 2025 respiratory virus season will be available in the fall, according to the agency.
Reference:
- KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases - (https://www.cdc.gov/ncird/whats-new/kp-3-1-1-is-the-predominant-variant.html)
Source-IANS
COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to ...
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to ...
COVID-19 Virus Evolves, Invades Central Nervous System
Discover how a specific mutation in the SARS-CoV-2 spike protein might increase the risk of COVID-19 infections in the brain.
Discover how a specific mutation in the SARS-CoV-2 spike protein might increase the risk of COVID-19 infections in the brain.
